Skip to content

Clinical trials

Lung Diseases trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Country / region: United Kingdom Clear all

87 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20044
20051
20083
20094
20102
20115
20124
20131
20143
20153
20167
20179
20184
20197
20204
20214
20222
20236
20246
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46
Recruiting14
Active, not recruiting10
Terminated10
Unknown status5
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca15
Royal Brompton & Harefield NHS Foundation Trust7
Eli Lilly and Company5
Bayer2
Complexa, Inc.2
Hoffmann-La Roche2
Imperial College London2
Nottingham University Hospitals NHS Trust2
Pneumacare Ltd2
Taiho Oncology, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases87
Respiratory Tract Diseases42
Pulmonary Disease, Chronic Obstructive16
Asthma15
Carcinoma, Non-Small-Cell Lung14
Lung Neoplasms14
Lung Diseases, Obstructive13
Respiratory Tract Neoplasms11
Thoracic Neoplasms11
Bronchial Diseases10

Trials

Showing 1 to 25 of 87. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.